T-cell lymphoblastic lymphoma presenting as bilateral multinodular breast masses: A case report and review of the literature

American Journal of Hematology

Volumn 80, Issue 3, 2005, Pages 216-222

  Vakiani, Efsevia ^a   Savage, David G ^a   Pile Spellman, Eliza ^a   El Tamer, Mahmoud ^a   Singh, Ila R ^a   Murty, Vundavalli S ^a   Alobeid, Bachir ^a   Bhagat, Govind ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Breast; T cell lymphoblastic lymphoma

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; GROWTH FACTOR;

ADULT; BRAIN RADIATION; BREAST BIOPSY; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HERPES ZOSTER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPHOBLASTOMA; MAMMOGRAPHY; MEDIASTINUM; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SYMPTOM; T CELL LYMPHOMA;

ADULT; BREAST NEOPLASMS; CRANIAL IRRADIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOMA, LYMPHOBLASTIC; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION;

EID: 27644527137     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20448     Document Type: Review

References (42)

1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: linical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780-2795.
2. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
3. Knowles DM. Lymphoblastic lymphoma. In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams & Wilkins; 1992. p. 715-747.
4. Thomas DA, Kantarjian HM. Lymphoblastic lymphoma. Hematol Oncol Clin North Am 2001;15:51-95.
5. Borowitz M. Acute lymphoblastic leukemia. In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams & Wilkins; 1992. p. 1295-1314.
6. Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R, Romejko-Jarosinska J, Zwolinski J, Walewski J. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002;99:4379-4385.
7. Sioutos N, Bagg A, Michaud GY, Irving SG, Hartmann DP, Siragy H, Oliveri DR, Locker J, Cossman J. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1995;4:8-13.
8. Bottaro M, Berti E, Biondi A, Migone N, Crosti L. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994;83:3271-3278.
9. Mitelman F, editor. An international system for human cytogenetic nomenclature (1995): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, TN, USA, October 9-13, 1994. Basel: S. Karger; 1995.
10. Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol 1999;26:357-364.
11. Cohen PL, Brooks JJ. Lymphomas of the breast. A clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer 1991;67:1359-1369.
12. Arber DA, Simpson JF, Weiss LM, Rappaport H. Non-Hodgkin's lymphoma involving the breast. Am J Surg Pathol 1994;18:288-295.
13. Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990;66:2602-2611.
14. Vianello F, Sgarabotto D, Stefani PM, Radossi P, Sartori R, Sartori D, Girolami A. Primary breast lymphoma. Forum (Genova) 1998;8:188-195.
15. Kosaka M, Tsuchihashi N, Takishita M, Miyamoto Y, Okagawa K, Gotoh T, Saito S, Komaki M, Morimoto T, Sano T. Primary adult T-cell lymphoma of the breast. Acta Haematol (Basel) 1992;87:202-205.
16. Aguilera NS, Tavassoli FA, Chu WS, Abbondanzo SL. T-cell lymphoma presenting in the breast: a histologic, immunophenotypic and molecular genetic study of four cases. Mod Pathol 2000;13:599-605.
17. Yumuk PF, Aydiner A, Topuz E, Cabioglu N, Dogan O. T-cell lymphoblastic lymphoma presenting with a breast mass. Leuk Lymphoma 2004;45:833-836.
18. Sung DW, Lim JW, Yoon Y, Kim YW, Lee JH, Cho KS. Primary breast lymphoma. J Korean Med Sci 1993;8:210-213.
19. Morel P, Lepage E, Brice P, Dupriez B, D'Agay MF, Fenaux P, Gosselin B, Banters F, Gisselbrecht C. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 1992;10:1078-1085.
20. Au WY, Chan AC, Chow LW, Liang R. Lymphoma of the breast in Hong Kong Chinese. Hematol Oncol 1997;15:33-38.
21. Carbone A, Volpe R, Tirelli U, Veronesi A, Galligioni E, Trovo MG, Grigoletto E. Primary lymphoblastic lymphoma of the breast. Clin Oncol 1982;8:367-373.
22. Ellegaard J, Bendix-Hansen K, Boesen AM, Thorling K, Hokland P. Breast tumour as a first manifestation of extramedullary relapse in acute lymphoblastic leukaemia. Scand J Haematol 1984;33:288-294.
23. Diebold J, Jaffe E, Raphael M, Warnke R. Burkitt lymphoma. In: Jaffe E, Harris N, Stein H, Vardiman J, editors. Pathology and genetics: tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p 181-184.
24. Dardenne M, de Moraes MC, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994;134:2108-2114.
25. Ceredig R, Rolink T. A positive look at double-negative thymocytes. Nat Rev Immunol 2002;2:888-897.
26. Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood 2001;97:270-276.
27. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90:1345-1364.
28. Tomeczkowski J, Frick D, Schwinzer B, Wittner N, Ludwig WD, Reiter A, Weite K, Sykora KW. Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells. Leukemia 1998;12:1221-1229.
29. Nishii K, Kita K, Miwa H, Kawakami K, Nakase K, Masuya M, Morita N, Omay SB, Otsuji N, Fukumoto M, et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 1992;6:662-668.
30. Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, Davi F, Landman-Parker J, Quartier P, Buzyn A, Delabesse E, Valensi F, Macintyre E. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003;101:2693-2703.
31. Hashimoto M, Yamashita Y, Mori N. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias. J Pathol 2002;197:341-347.
32. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25: 396-399.
33. Robertson PB, Neiman RS, Worapongpaiboon S, John K, Orazi A. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. Mod Pathol 1997;10:277-282.
34. Dworzak MN, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A, Schollhammer A, Steiner G, Ambros PF, Gadner H. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994;83:415-425.
35. Bernard G, Breittmayer JP, de Matteis M, Trampont P, Hofman P, Senik A, Bernard A. Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 1997;158:2543-2550.
36. Horie R, Gattei V, Ito K, Imajo-Ohmi S, Tange T, Miyauchi J, Pinto A, Degan M, De Iuliis A, Tassan Mazzocco F, Rossi FM, Higashihara M, Watanabe T. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms. Am J Pathol 1999;155:2029-2041.
37. Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol 1999;90: 157-164.
38. Ohtsuka E, Kikuchi H, Nasu M, Takita-Sonoda Y, Fujii H, Yokoyama S. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression. Leuk Lymphoma 1994;15:303-310.
39. Tabrizifard S, Olaru A, Plotkin J, Fallahi-Sichani M, Livak F, Petrie HT. Analysis of transcription factor expression during discrete stages of postnatal thymocyte differentiation. J Immunol 2004;173:1094-1102.
40. Kaneko Y, Frizzera G, Maseki N, Sakurai M, Komada Y, Hiyoshi Y, Nakadate H, Takeda T. A novel translocation. t(9;17)(q34;q23), in aggressive childhood lymphoblastic lymphoma. Leukemia 1988;2:745-748.
41. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L, Schemel V, Fonatsch C, Ludwig WD, Hiddemann W, Dreyling MH. Molecular analysis of the CALM/ AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 2000;14:93-99.
42. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 2002;94:2738-2744.